Zetia Buyers Granted Cert. Despite Small Class Size

By Bryan Koenig (August 24, 2020, 5:28 PM EDT) -- A Virginia federal judge granted class certification Friday to Zetia direct buyers accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market, rejecting attacks on the small size of the class and the companies representing them.

U.S. District Judge Rebecca Beach Smith fully adopted the recommendation for certification of U.S. Magistrate Judge Douglas E. Miller, finding that 35 direct buyers are enough for a class, and they'll be adequately represented by named plaintiffs FWK Holdings LLC, Cesar Castillo Inc. and Rochester Drug Co-Operative Inc., despite RDC's bankruptcy and other issues highlighted by...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!